Gabapentin
- Product NDC
- 83301-0002
- 11-digit product format
- 833010002
- Labeler code
- 83301
- Product ID
- 83301-0002_423fc29b-e05c-0d6b-e063-6294a90abf30
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- Mullan Pharmaceutical Inc.
- Application
- ANDA207057
- Marketing category
- ANDA
- Marketing start
- 2024-01-01
- Substance
- GABAPENTIN
- Active strength
- 800 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Gabapentin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GABAPENTIN | 800 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6CW7F3G59X |
| Rxcui | 310433, 310434 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 83301-0002-1 | Gabapentin | 100 in 1 BOTTLE, PLASTIC | TABLET, COATED | 100 | | 4 |
| 83301-0002-2 | Gabapentin | 500 in 1 BOTTLE, PLASTIC | TABLET, COATED | 500 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 83301-0002 | GABAPENTIN TABLET, COATED [MULLAN PHARMACEUTICAL INC.] | 3 | Current NDC, 2 package rows | 20250223_47a22de2-ec66-45be-8648-89ed3ab6e67e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 83301-0002-1 | 83301000201 | 100 TABLET, COATED in 1 BOTTLE, PLASTIC (83301-0002-1) | 2024-01-01 | No | No | Current |
| 83301-0002-2 | 83301000202 | 500 TABLET, COATED in 1 BOTTLE, PLASTIC (83301-0002-2) | 2024-01-01 | No | No | Current |